CORC

在结果中检索

CORC

浏览/检索结果: 共18条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Noninvasive and Accurate Detection of Hereditary Hearing Loss Mutations with Buccal Swab Based on Droplet Digital PCR 期刊论文
2018, 卷号: 90, 期号: 15, 页码: 8919-8926
作者:  Wang, Fang;  Zhu, Lingxiang;  Liu, Baoxia;  Zhu, Xiurui;  Wangt, Nan
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 study 期刊论文
2018, 卷号: 7, 期号: 4, 页码: 1043-1055
作者:  Huang, Xiaojun;  Qiu, Lugui;  Jin, Jie;  Zhou, Daobin;  Chen, Xiequn
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Recanalization of native superficial femoral artery chronic total occlusion after failed femoropopliteal bypass in patients with critical limb ischemia 期刊论文
2018, 卷号: 31, 期号: 2, 页码: 207-215
作者:  Li, Zhenjiang;  Feng, Rui;  Qin, Feng;  Zhao, Zhiqing;  Yuan, Liangxi
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from t 会议论文
BLOOD, 2018-11-29
作者:  Fu, Weijun;  Lu, Jin;  Jin, Jie;  Xu, Yan;  Wu, Depei
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
Efficacy and Safety of Eltrombopag in Chinese Patients with Chronic Immune Thrombocytopenia: Stage 2 Results from a Multicenter Phase III Study 会议论文
BLOOD, 2018-11-29
作者:  Yang, Renchi;  Liu Xiaofan;  Li, Junmin;  Hou, Ming;  Jie, Jin
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from t 期刊论文
2018, 卷号: 132
作者:  Fu, Weijun;  Lu, Jin;  Jin, Jie;  Xu, Yan;  Wu, Depei
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Efficacy and Safety of Eltrombopag in Chinese Patients with Chronic Immune Thrombocytopenia: Stage 2 Results from a Multicenter Phase III Study 期刊论文
2018, 卷号: 132
作者:  Yang, Renchi;  Liu Xiaofan;  Li, Junmin;  Hou, Ming;  Jie, Jin
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study 期刊论文
2017, 卷号: 10, 期号: 1, 页码: 137
作者:  Hou, Jian;  Jin, Jie;  Xu, Yan;  Wu, Depei;  Ke, Xiaoyan
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/04
Ixazomib plus lenalidomide-dexamethasone (IRd) vs placebo-Rd in patients (pts) with relapsed/refractory multiple myeloma (RRMM): China continuation of TOURMALINE-MM1. 期刊论文
2016, 卷号: 34, 期号: 15
作者:  Hou, Jian;  Jin, Jie;  Xu, Yan;  Wu, Depei;  Ke, Xiaoyan
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
Ixazomib plus lenalidomide-dexamethasone (IRd) vs placebo-Rd in patients (pts) with relapsed/refractory multiple myeloma (RRMM): China continuation of TOURMALINE-MM1. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Hou, Jian;  Jin, Jie;  Xu, Yan;  Wu, Depei;  Ke, Xiaoyan
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace